Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Times Interest Earned (2023 - 2025)

Arcus Biosciences has reported Times Interest Earned over the past 3 years, most recently at -$57.0 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$57.0 for Q4 2025, down 10.68% from a year ago — trailing twelve months through Dec 2025 was -$48.25 (up 41.52% YoY), and the annual figure for FY2025 was -$48.25, up 41.52%.
  • Times Interest Earned for Q4 2025 was -$57.0 at Arcus Biosciences, down from -$47.33 in the prior quarter.
  • Over the last five years, Times Interest Earned for RCUS hit a ceiling of -$4.0 in Q2 2025 and a floor of -$122.0 in Q1 2025.
  • Median Times Interest Earned over the past 3 years was -$54.25 (2024), compared with a mean of -$60.35.
  • Peak annual rise in Times Interest Earned hit 54.92% in 2025, while the deepest fall reached 662.5% in 2025.
  • Arcus Biosciences' Times Interest Earned stood at -$80.0 in 2023, then surged by 35.62% to -$51.5 in 2024, then fell by 10.68% to -$57.0 in 2025.
  • The last three reported values for Times Interest Earned were -$57.0 (Q4 2025), -$47.33 (Q3 2025), and -$4.0 (Q2 2025) per Business Quant data.